NMNAT2 and tauopathy: Reduced NMNAT2 levels have already been linked to tauopathy in mice and to decreased cognitive function in humans (Ljungberg et al., 2012, Ali et al., 2016), but the severity of the phenotype in mice lacking NMNAT2 suggests a complete lack of the protein is unlikely to directly model any neurodegenerative conditions.